Burkoth William T. 4
4 · NovoCure Ltd · Filed Jun 4, 2018
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Burkoth William T.
Director
Transactions
- Award
Options to Buy Ordinary Shares
2018-05-31+12,345→ 12,345 totalExercise: $31.45Exp: 2028-05-31→ Ordinary Shares (12,345 underlying) - Award
Restricted Stock Unit
2018-05-31+6,145→ 6,145 total→ Ordinary Shares (6,145 underlying)
Footnotes (3)
- [F1]Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.
- [F3]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.